methyl 5-methyl-1H-imidazole-4-carboxylate hydrochloride, 95.0%, 5g

2-(Pyridin-2-yl)-1H-benzo[d]imidazole-6-carboxylic acid, 95.0%, 250mg

6,7-DIHYDRO-2H-BENZO[6,7]CYCLOHEPTA[1,2-C]PYRIDAZIN-3(5H)-ONE, 95.0%, 500mg

(1S,3R,4S)-(+)-4-AZIDO-3-[(TERT-BUTOXYCARBONYL)AMINO]CYCLOHEXANECARBOXYLIC ACID ETHYL ESTER, 95.0%, 1g

1,4-Diazabicyclo[2.2.2]octane Dihydriodide>98.0%(T)1g

D-Glucopyranoside, Methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)Methyl]phenyl]-, tetraacetate, 95%, 1g

Methyl 2-(bromomethyl)-4-nitrobenzoate, 95.0%, 1g

((2,6-dichlorophenyl)sulfonyl)leucine, 95.0%, 1g

4-(Trifluoromethyl)phthalic acid, 95.0%, 25g

Bis(2-chlorophenyl)methanol, 95%, 5g

Colonne capillaire GC ROTI®Cap-FFAP, 60 m, 0,32 mm, 0,25 µm, 1 pièce(s)

6-Nitrophthalide, 97.0%, 25g

5-Chloro-6-oxo-1,6-dihydropyridine-2-carboxylic acid, 95.0%, 1g